Related to Scientists Develop Nanochannel Electroporation Device for Precise Control of Transfection into Individual Cells

• Polyplus-Transfection Grants Roche Glycart Polyethylenimine License
  
• Oxford BioMedica Buys Manufacturing Facility from RecipharmCobra for £1.9M
  
• Horizon Licenses Minnesota Uni IP to Boost Rate of rAAV Gene Editing Platform
  
• Scientists Model Complex Curved 3-D DNA Nanostructures Using Modified Origami Approach
  
• Scientists Develop High-Capacity Nanoparticles for Targeted Delivery of Drug Cocktails
  
• Investigators Bank on Chemokine-Loaded Nanovaults for Treating Lung Cancer
  
• ExcellGene Extends Supply Agreement for Polyplus-Transfection's Reagents
  
• Scientists Develop Nanoliter System for Prolonged Single-Cell Imaging of ESC Proliferation
  
• Scientists Develop Communicating Nanoparticles that Boost Targeted Drug Delivery to Tumors
  
• Nanostructured Support Developed for Maintaining MSCs in Undifferentiated, Multipotent State
  
• Scientists Develop Aptamer Sensor for Monitoring Single-Cell Interactions in Real Time
  
• Researchers Develop VEGF-Mimetic Nanofibers for Ischemic Tissue Repair
  
• Diamyd Shifts Development Focus from Diabetes to Pain and CNS Disorders
  
• Scientists Uncover Why Cells Will Bite Off More Nanomaterial Than They Can Chew
  
• Chemokine Receptor-Targeting siRNA Nanoparticles Used to Reduce Damage in Multiple Disease Models
  
• Silence and Mirna Partner to Evaluate Delivery Systems for miRNA Therapeutics
  
• Roche Gives Arrowhead RNAi Assets and Facility in Madison, WI
  
• Nanolipid Vesicle Platform Developed that Uses Subattoliter Volumes for Screening Reactions
  
• Mirus and Reinnervate to Commercialize 3-D Transfection Kits
  
• Breast Cancer Stem Cells Succumb to Nanoparticle-Mediated Photothermal Therapy